The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 04, 2018

Filed:

Dec. 18, 2014
Applicant:

Axon Dx, Llc, Earlysville, VA (US);

Inventors:

Philip Couch, Honiton, GB;

Celeste E. Smith, Harrisonburg, VA (US);

Jeffrey A. Smith, Harrisonburg, VA (US);

Daniel Carter, Stoke-on-Trent, GB;

Assignee:

AXON DX, LLC, Earlysville, VA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01J 3/46 (2006.01); G06T 7/00 (2017.01); G01N 33/574 (2006.01); G01N 33/58 (2006.01); G01N 21/64 (2006.01); G02B 21/00 (2006.01); G06K 9/46 (2006.01); G06K 9/52 (2006.01); G06K 9/62 (2006.01); G06T 7/60 (2017.01); H04N 5/225 (2006.01); H04N 5/232 (2006.01);
U.S. Cl.
CPC ...
G06T 7/0012 (2013.01); G01N 21/6452 (2013.01); G01N 21/6458 (2013.01); G01N 33/574 (2013.01); G01N 33/58 (2013.01); G01N 33/582 (2013.01); G02B 21/008 (2013.01); G02B 21/0076 (2013.01); G06K 9/4661 (2013.01); G06K 9/52 (2013.01); G06K 9/6267 (2013.01); G06T 7/60 (2013.01); H04N 5/2256 (2013.01); H04N 5/23212 (2013.01); G01N 2021/6439 (2013.01); G06T 2207/30096 (2013.01); G06T 2207/30204 (2013.01);
Abstract

An optical system is provided for clinical diagnostics that include methods and apparatus for rapidly detecting and characterizing rare circulating cells such as, but not limited to, circulating tumor cells/circulating stems cells (CTC/CSCs) in a biological sample. The sample is processed for analyses, loaded onto a 'capture zone' in the optical system where, and subjected to a two stage optical process for very rapid detection and detailed characterization of detected cells. The detected rare cells are characterized with regards to biomarker profiles using fluorescent tags or chromophores for detection and optical imaging. Isolation of the captured rare cells is anticipated for down-stream assessments including, but not limited to, DNA, RNA, proteomic analyses and culture.


Find Patent Forward Citations

Loading…